194 related articles for article (PubMed ID: 4406686)
1. Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis.
Adams DD; Kennedy TH; Stewart RD
Br Med J; 1974 Apr; 2(5912):199-201. PubMed ID: 4406686
[TBL] [Abstract][Full Text] [Related]
2. LATS protector and abnormal thyroid stimulation in diffuse toxic goitre.
Stewart RD
N Z Med J; 1975 Jan; 81(531):24. PubMed ID: 1055311
[No Abstract] [Full Text] [Related]
3. Effects of long-acting thyroid stimulator (LATS) and LATS protector on human thyroid adenyl cyclase activity.
Kendall-Taylor P
Br Med J; 1973 Jul; 3(5871):72-5. PubMed ID: 4740444
[TBL] [Abstract][Full Text] [Related]
4. Long-acting thyroid stimulator (LATS) and long acting thyroid stimulator protector (LATS-P) in untreated thyrotoxicosis.
Hardisty CA; Hanford L; Humphries H; Munro DS
Clin Endocrinol (Oxf); 1981 Jun; 14(6):631-9. PubMed ID: 6895353
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of serum LATS activity and hyperfunction and autonomy of the thyroid gland in Graves' disease.
Hennemann G; Dolman A; Docter R; De Reus A; Van Zijl J
J Clin Endocrinol Metab; 1975 Jun; 40(6):935-41. PubMed ID: 1173367
[TBL] [Abstract][Full Text] [Related]
6. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
[TBL] [Abstract][Full Text] [Related]
7. Evidence that mouse thyroid stimulator does not stimulate the human thyroid gland.
Adams DD; Kennedy TH; Stewart RD
Aust N Z J Med; 1976 Aug; 6(4):300-4. PubMed ID: 1070985
[TBL] [Abstract][Full Text] [Related]
8. LATS-protector activity in thyrotoxicosis measured by thyroidal intracellular colloid droplet formation.
Shishiba Y; Miyachi Y; Takaishi M; Ozawa Y
J Clin Endocrinol Metab; 1978 May; 46(5):841-8. PubMed ID: 262769
[TBL] [Abstract][Full Text] [Related]
9. Evidence that both long-acting thyroid stimulator and long-acting thyroid stimulator-protector stimulate the human thyroid gland.
Holmes SD; Dirmikis SM; Martin TJ; Munro DS
J Endocrinol; 1979 Feb; 80(2):215-21. PubMed ID: 220366
[TBL] [Abstract][Full Text] [Related]
10. Evidence to suggest that LATS protector stimulates the human thyroid gland.
Adams DD; Kennedy TH
J Clin Endocrinol Metab; 1971 Jul; 33(1):47-51. PubMed ID: 5558041
[No Abstract] [Full Text] [Related]
11. Lack of refractoriness to stimulation with long acting thyroid stimulator of thyroid hormone synthesis and thyroid hormone secretion in mice in vivo.
Ikeda H; Nagataki S
Acta Endocrinol (Copenh); 1983 Mar; 102(3):392-5. PubMed ID: 6829264
[TBL] [Abstract][Full Text] [Related]
12. Relation between thyroid function and serum levels of long-acting thyroid stimulator.
Davis JC; Hipkin LJ; Summers VK; Gimlette TM
Acta Endocrinol (Copenh); 1975 Jul; 79(3):451-8. PubMed ID: 1173501
[TBL] [Abstract][Full Text] [Related]
13. The assay of Graves' immunoglobulins: a comparison of different methods.
Hardisty CA; Kendall-Taylor P; Atkinson S; Humphries H; Munro DS
Clin Endocrinol (Oxf); 1983 Jun; 18(6):637-44. PubMed ID: 6136348
[TBL] [Abstract][Full Text] [Related]
14. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
15. Hemiaplasia of the thyroid with thyrotoxicosis.
Mortimer PS; Tomlinson IW; Rosenthal FD
J Clin Endocrinol Metab; 1981 Jan; 52(1):152-5. PubMed ID: 7451642
[TBL] [Abstract][Full Text] [Related]
16. Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.
Ginsberg J; von Westarp C
CMAJ; 1986 May; 134(10):1141-7. PubMed ID: 2421862
[TBL] [Abstract][Full Text] [Related]
17. Influence of the long-acting thyroid stimulator (LATS) on radioiodine-labelled thyroxine and triiodothyronine in the thyroid of mice.
Emrich D; von Toll-Jürgens KH; zur Mühlen A Von
Endocrinology; 1970 Sep; 87(3):632-6. PubMed ID: 5424582
[No Abstract] [Full Text] [Related]
18. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.
Endo K; Kasagi K; Konishi J; Ikekubo K; Okuno T; Takeda Y; Mori T; Torizuka K
J Clin Endocrinol Metab; 1978 May; 46(5):734-9. PubMed ID: 45421
[TBL] [Abstract][Full Text] [Related]
19. LATS protector, the human thyroid stimulator.
Adams DD
N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
[No Abstract] [Full Text] [Related]
20. Proceedings: Studies on long-acting thyroid stimulator protector in serum containing long-acting thyroid stimulator.
Dirmikis S; Munro DS
J Endocrinol; 1975 Mar; 64(3):29P-30P. PubMed ID: 1173370
[No Abstract] [Full Text] [Related]
[Next] [New Search]